|
Volumn 2, Issue 1, 1996, Pages 13-18
|
Protease inhibitors: implications for HIV research and treatment.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
PROTEINASE INHIBITOR;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
DRUG COMBINATION;
DRUG EFFECT;
GENETICS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOLOGY;
PHYSIOLOGY;
VIRUS REPLICATION;
ANTIVIRAL AGENTS;
CD4 LYMPHOCYTE COUNT;
DRUG RESISTANCE, MICROBIAL;
DRUG THERAPY, COMBINATION;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HIV-1;
HUMANS;
VIRUS REPLICATION;
|
EID: 0029680901
PISSN: 1081454X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|